NRX Pharmaceuticals, Inc. (NRXP) stock
NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.45+0.30 (+13.95%)
Close on Nov 17, 2026Market cap $106.08MP/E –Yield –
NRX Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NRX Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -691.8%. For fiscal 2025 it was -2336.5%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2336.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1500.5% | – |
| Q1 FY2026 | Mar 31, 2026 | -133.9% | – |
| Q4 FY2025 | Dec 31, 2025 | 36.6% | – |
| Q3 FY2025 | Sep 30, 2025 | -2433.9% | – |
See a number that looks wrong?